Tilray Brands (TLRY) Non Operating Income (2017 - 2026)
Tilray Brands' (TLRY) quarterly Non Operating Income came in at -$6.6 million in Q2 2026, down 145.15% YoY from $14.7 million in Q2 2025, and down 181.91% on a QoQ basis from $8.1 million in Q1 2026.
Tilray Brands (TLRY) Non Operating Income (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Non Operating Income data on file, last reported at -$6.6 million in Q2 2026.
- Quarterly Non Operating Income fell 145.15% year-over-year to -$6.6 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$17.5 million (up 41.43% YoY) and the FY2026 annual result came in at -$23.7 million, up 21.0% from the prior year.
- Non Operating Income slipped to -$6.6 million in Q2 2026, from $8.1 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $71.0 million in Q1 2022 to a low of -$33.3 million in Q4 2024.
- A 5-year average of -$4.4 million and a median of -$9.2 million in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income plunged 1521.19% — and 2025, when it soared 235.1%.
- Tracing TLRY's Non Operating Income over 5 years: stood at -$18.4 million in 2022, then surged by 53.25% to -$8.6 million in 2023, then slumped by 285.57% to -$33.3 million in 2024, then soared by 62.98% to -$12.3 million in 2025, then soared by 46.16% to -$6.6 million in 2026.
- The last three Non Operating Income figures came in at -$6.6 million (Q2 2026), $8.1 million (Q1 2026), and -$12.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Tilray Brands | 516.11 Mn | 281.48 Mn | 90.52 Mn | -984,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -6.63 Mn |
| Feb 28, 2026 | 8.09 Mn |
| Nov 30, 2025 | -12.31 Mn |
| Aug 31, 2025 | -6.70 Mn |
| May 31, 2025 | 14.68 Mn |
| Feb 28, 2025 | -24.02 Mn |
| Nov 30, 2024 | -33.26 Mn |
| Aug 31, 2024 | 12.65 Mn |
| May 31, 2024 | -10.87 Mn |
| Feb 29, 2024 | -17.24 Mn |
| Nov 30, 2023 | -8.63 Mn |
| Aug 31, 2023 | -9.84 Mn |
| May 31, 2023 | -16.68 Mn |
| Feb 28, 2023 | 1.21 Mn |
| Nov 30, 2022 | -18.45 Mn |
| Aug 31, 2022 | -32.99 Mn |
| May 31, 2022 | 11.34 Mn |
| Feb 28, 2022 | 71.04 Mn |
| Nov 30, 2021 | 65.60 Mn |
| Aug 31, 2021 | 49.70 Mn |